Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Various studies have shown that the risk of suffering a urinary retention after knee or hip
prosthesis surgery is 10-80%. The aim of the study is to reduce this riks. For this purpose,
it is investigated whether a previously known drug (tamsulosin) which is used in bladder
emptying disorders, can achieve a reduction in urinary retention after surgery. After the
patients agree to participate in the study, they are examined in our urological clinic.
Uroflowmetry is performed with sonographic residual volume measurement and prostate volume
measurement. Furthermore, a standardized Voiding questionaire (IPSS) is completed. This study
is conducted as a double-blind study using a placebo control group. The drug / placebo is
taken once a day, five days before and two days after surgery. Subsequently, it is observed
whether it comes to a urinary retention or not. After the operation, no further urological
checks are planned or needed.